Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Depatuxizumab mafodotin
Trade Name
Synonyms ABT-414|depatux-m
Drug Descriptions

Depatuxizumab mafodotin (ABT-414) is an antibody-drug conjugate comprising an EGFR-targeted antibody linked to an anti-microtubule drug, which delivers the cytotoxic agent to EGFR-expressing cells, potentially resulting in increased tumor cell death and decreased growth of EGFR-overexpressing tumors (PMID: 26846818, PMID: 29075855, PMID: 31747009, PMID: 32371586).

DrugClasses EGFR Antibody 56
CAS Registry Number 1585973-65-4
NCIT ID C105612

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
ABBV-321 + Depatuxizumab mafodotin ABBV-321 Depatuxizumab mafodotin 0 0
Depatuxizumab mafodotin Depatuxizumab mafodotin 0 3
Depatuxizumab mafodotin + Gefitinib Depatuxizumab mafodotin Gefitinib 0 0
Depatuxizumab mafodotin + Radiotherapy + Temozolomide Depatuxizumab mafodotin Radiotherapy Temozolomide 0 0
Depatuxizumab mafodotin + Temozolomide Depatuxizumab mafodotin Temozolomide 0 1


Additional content available in CKB BOOST